No Data
Investors in Dong-E-E-JiaoLtd (SZSE:000423) Have Seen Notable Returns of 87% Over the Past Five Years
After a year, Dong-E-E-Jiao has重订 its incentive plan, with significant adjustments to the stocks grant price and restriction release threshold | Quick announcement summary.
① After a year, Dong-E-E-Jiao has revised its incentive plan, increasing the grant price of the initially granted restricted Stocks from 24.98 yuan per share to 37.22 yuan per share. ② There have also been significant adjustments to the performance assessment requirements at the company level, with the revised net asset return assessment absolute value being higher than before the revision.
Guolian's investment strategy for the CSI SWS Health Care index in 2025: Look at space for incremental growth and at structure for existing assets.
Looking ahead to the CSI SWS Health Care index in 2025, from the perspective of incremental growth, attention should be paid to the long-term development of three major areas: medical insurance, self-paying, and overseas expansion; from the perspective of existing growth, attention should be paid to the essence of medicine and Medical.
While Private Companies Own 33% of Dong-E-E-Jiao Co.,Ltd. (SZSE:000423), Retail Investors Are Its Largest Shareholders With 45% Ownership
Announcement Highlights | In the first 11 months, SUNSHINE INS's original premium income exceeded 120 billion yuan; GCL TECH plans to allot up to 1.56 billion shares, net raising approximately 1.53 billion Hong Kong dollars.
In the first 11 months, SUNSHINE INS's original premium income exceeded 120 billion yuan; the major Shareholder of CHENGDU EXPWAY won a highway project worth over 10 billion yuan.
China Resources Pharma Increases Stake in Dong-E-E-Jiao
Dong-E-E-Jiao Co.,Ltd.'s (SZSE:000423) Shareholders Might Be Looking For Exit
No Data
